Expect 10 million vaccine dosage to be ready by March: Pankaj R Patel, Zydus Cadila

ZyCov-D is a potential vaccine candidate for Ztdus Cadila. It has got DCGI nod for Phase -III trial. The company will now be initiating Phase III clinical trials in around 30,000 volunteers. ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials. Pankaj R Patel, CMD, Zydus Group, in conversation with ETNOW.